102 related articles for article (PubMed ID: 35695271)
1. Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study.
Bin Sawad A; Jackimiec J; Bechter M; Hull M; Yeaw J; Wang Y; Diaz GA
J Med Econ; 2022; 25(1):848-856. PubMed ID: 35695271
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): A systematic review.
Bin Sawad A; Jackimiec J; Bechter M; Trucillo A; Lindsley K; Bhagat A; Uyei J; Diaz GA
Mol Genet Metab; 2022; 137(1-2):153-163. PubMed ID: 36049366
[TBL] [Abstract][Full Text] [Related]
3. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
Rajagopalan K; Rashid N; Gopal D; Doshi D
Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population.
Mantel J; Chitnis AS; Ruppenkamp J; Holy CE; Daccach J
J Med Econ; 2021; 24(1):10-18. PubMed ID: 33267624
[TBL] [Abstract][Full Text] [Related]
5. Health care resource utilization and costs among patients with spasticity or cervical dystonia.
Hull M; Danchenko N; Anupindi VR; DeKoven M; He J; Bouchard J
J Manag Care Spec Pharm; 2024 Jan; 30(1):86-97. PubMed ID: 38055046
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency.
Diaz GA; Schulze A; McNutt MC; Leão-Teles E; Merritt JL; Enns GM; Batzios S; Bannick A; Zori RT; Sloan LS; Potts SL; Bubb G; Quinn AG
J Inherit Metab Dis; 2021 Jul; 44(4):847-856. PubMed ID: 33325055
[TBL] [Abstract][Full Text] [Related]
7. Economic and clinical burden of managing transfusion-dependent β-thalassemia in the United States.
Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
J Med Econ; 2023; 26(1):924-932. PubMed ID: 37432699
[TBL] [Abstract][Full Text] [Related]
8. The role and control of arginine levels in arginase 1 deficiency.
Diaz GA; Bechter M; Cederbaum SD
J Inherit Metab Dis; 2023 Jan; 46(1):3-14. PubMed ID: 36175366
[TBL] [Abstract][Full Text] [Related]
9. Natural history of arginase 1 deficiency and the unmet needs of patients: A systematic review of case reports.
Bin Sawad A; Pothukuchy A; Badeaux M; Hodson V; Bubb G; Lindsley K; Uyei J; Diaz GA
JIMD Rep; 2022 Jul; 63(4):330-340. PubMed ID: 35822089
[TBL] [Abstract][Full Text] [Related]
10. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims.
Garris C; Shah M; Farrelly E
Cost Eff Resour Alloc; 2015; 13():9. PubMed ID: 26019689
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
Patel AM; Chang E; Paydar C; Reddy SR
J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
[TBL] [Abstract][Full Text] [Related]
14. Arginase 1 Deficiency in Patients Initially Diagnosed with Hereditary Spastic Paraplegia.
McNutt MC; Foreman N; Gotway G
Mov Disord Clin Pract; 2023 Jan; 10(1):109-114. PubMed ID: 36698992
[TBL] [Abstract][Full Text] [Related]
15. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
[TBL] [Abstract][Full Text] [Related]
17. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
18. National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United States.
Patel C; Pilon D; Gupta D; Morrison L; Lafeuille MH; Lefebvre P; Benson C
J Med Econ; 2022; 25(1):792-807. PubMed ID: 35635250
[TBL] [Abstract][Full Text] [Related]
19. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy.
Shaker M; Chalil JM; Tran O; Vlahiotis A; Shah H; King T; Green TD; Greenhawt M
Ann Allergy Asthma Immunol; 2020 Apr; 124(4):357-365.e1. PubMed ID: 31954759
[TBL] [Abstract][Full Text] [Related]
20. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
